Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.7 USD | -1.52% |
|
-1.62% | +27.30% |
13/05 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
10/05 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.30% | 6.31Cr | |
+23.13% | 4.69TCr | |
+37.55% | 3.91TCr | |
-8.73% | 3.85TCr | |
+28.09% | 3.1TCr | |
-12.26% | 2.61TCr | |
+10.57% | 2.59TCr | |
+45.05% | 1.42TCr | |
+32.23% | 1.25TCr | |
-6.56% | 1.14TCr |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Instil Bio Says 1-for-20 Reverse Stock Split to Take Effect on Dec. 7